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Abstract
Background: Three members of the Plasmodium vivax merozoite surface protein-3 (PvMSP3) family (PvMSP3-a, PvMSP3-b
and PvMSP3-c) were initially characterized and later shown to be part of a larger highly diverse family, encoded by a cluster
of genes arranged head-to-tail in chromosome 10. PvMSP3-a and PvMSP3-b have become genetic markers in
epidemiological studies, and are being evaluated as vaccine candidates. This research investigates the gene and protein
expression of the entire family and pertinent implications.
Methodology/Principal Findings: A 60 kb multigene locus from chromosome 10 in P. vivax (Salvador 1 strain) was studied
to classify the number of pvmsp3 genes present, and compare their transcription, translation and protein localization
patterns during blood-stage development. Eleven pvmsp3 paralogs encode an N-terminal NLRNG signature motif, a central
domain containing repeated variable heptad sequences, and conserved hydrophilic C-terminal features. One additional ORF
in the locus lacks these features and was excluded as a member of the family. Transcripts representing all eleven pvmsp3
genes were detected in trophozoite- and schizont-stage RNA. Quantitative immunoblots using schizont-stage extracts and
antibodies specific for each PvMSP3 protein demonstrated that all but PvMSP3.11 could be detected. Homologs were also
detected by immunoblot in the closely related simian species, P. cynomolgi and P. knowlesi. Immunofluorescence assays
confirmed that eight of the PvMSP3s are present in mature schizonts. Uniquely, PvMSP3.7 was expressed exclusively at the
apical end of merozoites.
Conclusion/Significance: Specific proteins were detected representing the expression of 10 out of 11 genes confirmed as
members of the pvmsp3 family. Eight PvMSP3s were visualized surrounding merozoites. In contrast, PvMSP3.7 was detected
at the apical end of the merozoites. Pvmsp3.11 transcripts were present, though no corresponding protein was detected.
PvMSP3 functions remain unknown. The ten expressed PvMSP3s are predicted to have unique and complementary
functions in merozoite biology.
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Introduction
Plasmodium vivax causes extensive morbidity in over 95 countries,
accounting for 2.85 billion people exposed to transmission, and the
potential to cause severe disease and sometimes death [1,2]. There
is an urgency to reduce and ultimately eliminate these infections,
with emphasis on the prevention and treatment of this species’
active and quiescent liver-stage forms, as well as blood-stage forms
that are the cause of disease manifestation and transmission [3–5].
The merozoite stage of the parasite’s life cycle represents one
possible target of intervention [6]. Plasmodium merozoites are single
cell Apicomplexan parasitic organisms that are ripe with proteins
that are critical for the successful invasion and propagation of the
parasite within erythrocytes. The merozoites have a highly
structured protein surface coat comprised of ten or more unique
proteins. In electron transmission microscopy images (shown for P.
vivax) the merozoite surface has a spiked appearance, suggesting an
organized presentation of the proteins at the surface [7]. The
merozoite’s apical pole contains rhoptry, microneme and other
organelles with proteins known to be involved in the attachment to
red blood cells, invasion and host cell modification [8]. Within
minutes after being released from infected erythrocytes, each
merozoite progeny must properly attach to and invade a new host
red blood cell. A cascade of molecular adhesion and enzymatic
processes occur, with various points for possible intervention, as
the merozoite’s apical pole initiates the entry process and the
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parasite becomes enveloped and secluded within the selected host
cell. Both the surface molecules and proteins that become localized
at the apical pole are important for the successful invasion of
erythrocytes by merozoites. The surface coat and organellar
proteins are therefore of high interest as possible malaria vaccine
candidates or drug targets, for P. vivax and other species. However,
the full set and specific roles of the composite proteins are still
largely under defined [9–12].
The MSP3 family of P. vivax was originally characterized based
on the identification of three related genes and encoded proteins:
pvmsp3-a, pvmsp3-b, and pvmsp3-c [13,14]. Each of these pvmsp3
genes encodes a protein with a predominant central alanine-rich
domain containing heptad repeats predicted to form a-helical
secondary and coiled-coil tertiary structures [15]. PvMSP3-a and
PvMSP3-b were shown to be present at the surface of merozoites,
within schizont-infected red blood cells (RBCs), as well as free
merozoites, despite their lack of a transmembrane domain or GPI-
lipid modification site [13,14]. The PvMSP3 members were
therefore predicted to be associated with other merozoite surface
molecules, possibly through protein-protein interactions involving
the coiled-coil domains [13,14], similarly as suggested for the
initially described P. falciparum MSP3 [16,17]. The coiled-coil
structure in PfMSP3.1 has been shown experimentally by ‘H
NMR spectroscopy with the analysis of synthesized peptide,
whereby the a-helices were found to contain 38 amino acids [18].
The a-helical secondary structures present in recombinant
PfMSP3.1 [19], rPvMSP3-a (PvMSP3.10) and rPvMSP3-b
(PvMSP3.3) [20] were also confirmed by far-UV CD spectroscopy.
The central coiled-coil domains are highly polymorphic, while the
flanking N- and C-terminal regions are relatively more conserved,
but still polymorphic. As shown for pvmsp3-a and pvmsp3-b, the
allelic polymorphism observed in the central domain can include
many point mutations as well as large insertions and deletions
[21,22]. Diversity studies with isolates from around the world
continue to show extensive polymorphism in these genes and the
encoded proteins, and the pvmsp3 alleles have therefore become
highly regarded as genetic tools to distinguish different parasite
isolates and study population dynamics [23]. They have also been
regarded as potential vaccine candidates, following in the path of
PfMSP3 [24,25]. Immune response studies carried out to date in
Brazil assessing naturally acquired immunity to PvMSP3-a show
the presence of broadly recognized B cell epitopes from the central
region of PvMSP3a, IgG1 and IgG3 antibody subclasses
associated with increased exposure to the parasite, and the
association of HLA types with such responses [26,27]. Others have
reported a predominance of IgG1 and IgG2, and an association
with anemia [28].
With the discovery of three members of the P. vivax MSP3
family (PvMSP3a, b, and c proteins), prior to the genome era, an
unusual defining characteristic signature motif with the consensus
sequence NLRNG was noted immediately after the signal peptide
and shown to be conserved in homolog proteins present in P.
knowlesi and P. falciparum [13]. This signature motif and the
availability of Plasmodium genome sequences facilitated the
recognition of additional family members in the context of a
multigene locus of msp3 genes in P. vivax and P. falciparum the [29–
32].
In the current study, we aimed to investigate the structure and
expression of each of the putative P. vivax msp3 genes present in a
60 kb multigene locus in chromosome 10 [30]. Whether all or a
subset of these predicted msp3 ORFs are transcribed and translated
in blood-stage parasites was unknown, and this information is
relevant for understanding the parasite’s biology and the potential
of family members as vaccine or drug targets. We have succeeded
in further characterizing and defining the expression of this gene
family, and we also report the discovery of a novel apically located
protein that may be functionally important for the invasion of
RBCs.
Results
Definition of the pvmsp3 Multigene Locus with Eleven
Putative PvMSP3 Members Encoded in Tandem
The P. vivax genome database shows that the pvmsp3-a,
pvmsp3-b and pvmsp3-c genes encoding the originally identified
members of the MSP3 family [13,14] are located in chromo-
some 10 within a segment of DNA spanning close to 60 kb
(www.plasmodb.org). Our analyses of this region and the
surrounding DNA has resulted in eight additional open reading
frames (ORF) within the ,60 kb segment being classified as
members of the pvmsp3 family and the complete set of eleven
msp3 genes being annotated as pvmsp3.1 through pvmsp3.11 [30]
(Fig. 1A, Table 1). Based on their position in the series, the
pvmsp3-a, pvmsp3-b, and pvmsp3-c genes have been renamed
pvmsp3.10, pvmsp3.3 and pvmsp3.1, respectively. Each gene is
contained in a single exon, without intervening sequences, and
they are positioned head-to-tail within the multigene locus. The
ATG start codon of each member of the pvmsp3 family is
preceded by an adenine at position -3, forming the expected
consensus start sequence described in Plasmodium [33].
Three characteristic protein features have been confirmed for
the proteins encoded by all eleven members of the pvmsp3
family: an NLRNG motif immediately following the putative
signal peptide cleavage site, a predominant central alanine-rich
region with predicted coiled-coil domains, and a C-terminal
motif containing a glutamate-rich domain (Fig. 1B, 2, S1, S2
and S3).
To arrive at this conclusion, the MEME (Multiple Em for Motif
Elicitation) algorithm was used to search for significantly
overrepresented amino acid residues in each predicted PvMSP3
family member. Our MEME analysis also included the full-length
sequences of the following MSP3 orthologs from P. falciparum, P.
knowlesi and P. cynomolgi, respectively: PfMSP3.1 (FC27 and CSL2
strains), PkMSP3140, PkMSP3172, and PcyMSP3.10 (Berok strain)
(Fig. 2, sequence accession numbers in Table S2). It is of special
interest that the NLRNG motif is present in each deduced MSP3
sequence, despite otherwise quite divergent MSP3 sequences in all
of these species, whether closely (P. cynomolgi and P. knowlesi) or
distantly (P. falciparum) related to P. vivax [34].
Using the Multicoil algorithm (http://groups.csail.mit.edu/cb/
multicoil/cgi-bin/multicoil.cgi), the central alanine-rich region of
all predicted PvMSP3s scores significantly above the cut-off value
for the formation of coiled-coils. The central domain spans the
majority (66.1%–84.2%) of the total amino acid sequences, and
this domain differs in size for each member of the family (Table 1,
Fig. 1B, S1 and S2). Though the alanine residues are often in
positions a and d of the tandemly repeated heptad AxxAxxx of
other MSP3 proteins, we found that the predicted heptad repeat in
the PvMSP3 family is better described as having any hydrophobic
residue, such as Valine, Isoleucine, Serine or Alanine in the a and
d positions (Fig. 2B, S1 and S2).
A complete protein sequence analysis revealed that Ala, Glu,
and Lys account for more than 50% of the amino acid
composition of the entire PvMSP3 family, although there is low
amino acid sequence identity between family members (Table 1).
They also have different calculated molecular weights ranging
from 41.1 kDa to 134 kDa. The isoelectric point (pI) of 10 of the
11 predicted proteins is close to 5.0, with the one exception being
Plasmodium vivax Merozoite Surface Protein3 Family
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the smallest predicted member, PvMSP3.11, with a pI of 4.2
(Table 1). It is worth noting that in further experimental studies
(below) we did not detect any protein expressed from this gene.
Thus, the predicted molecular weights of the PvMSP3s that were
found to be expressed range from 90.6 kDa to 134 kDa, although
each of them consistently migrates significantly higher by SDS-
PAGE (see below), as reported earlier for the PvMSP3a and b
family members [13,14].
Global pairwise alignment of the putative PvMSP3 sequences
results in similarity scores well below 50%; however, identity
scores are much higher between PvMSP3.6 and PvMSP3.8
(81.8%), PvMSP3.4 and PvMSP3.5 (72.6%), and PvMSP3.7 and
PvMSP3.9 (63.2%) (Table 2). Alignment of the predicted amino
acids of these proteins showed varying identity and similarity
percentages, for example, PvMSP3.6 and PvMSP3.8 scored 88
and 82%, for similarity and identity, respectively (Table 2),
suggesting a common ancestry and occurrence of gene
duplications, compared to the highly polymorphic central
domains.
The third characteristic motif of PvMSP3 members is a
hydrophilic region in the C-terminus, which contains a high
content of acidic amino acids in clusters, particularly glutamic acid
and aspartic acid (Fig. 1B, 2C and S3), and lacks a C-terminal
transmembrane motif, or any site for post-translational GPI
modifications. Notably, all PvMSP3 members also lack a leucine-
zipper, which is typical at the terminal end of MSP3 proteins in P.
falciparum [16,17 31,35].
An additional ORF was identified between pvmsp3.9 and
pvmsp3.10 with the gene ID: PVX_097715 (Fig. 1A). The putative
protein sequence encoded by this ORF lacks the typical coiled-coil
region, the N-terminal NLRNG motif and the C-terminal motif
containing the glutamate-rich domain; therefore, it has not been
included as a member of this family. Likewise, the 59
(PVX_097665) and 39 (PVX_097730) ORFs flanking the pvmsp3
cluster do not have characteristic features of pvmsp3 genes [13,14].
These are annotated in PlasmoDB database as the 4-dipho-
sphocytidyl-2c-methyl-D-erythritol kinase gene and a hypothetical gene,
respectively.
Figure 1. Schematic depicting the eleven members of the pvmsp3 gene family in chromosome 10 and characteristic features of all
PvMSP3 family members. 1A. Pvmsp3 gene family members are arranged in tandem in chromosome 10, and flanked by unrelated loci
(PVX_097665 and PVX_097730). The eleven pvmsp3 genes are represented as open boxes and labeled as pvmsp3.1 through pvmsp3.11. The gene IDS
are: PVX_097670, PVX_097675, PVX_097680, PVX_097685, PVX_097690, PVX_097695, PVX_097700, PVX_097705, PVX_097710, PVX_097720,
PVX_097725, respectively. The originally described pvmsp3 family members (a, b and c) are also marked as such. One ORF, PVX_097715, does not
encode characteristic features of PvMSP3 proteins (Fig. 2) and has thus been excluded as a member of the pvmsp3 gene family. 1B. Each PvMSP-3 is
depicted with the protein’s size in amino acids noted. The predominant centrally located coiled-coil structures of each protein are depicted by blue
coiled cylinders. Other characteristic features include a conserved NLRNG motif (triangle) near the N-terminus and a glutamate-rich motif (red
rectangles) near the C-terminus. Putative signal peptides (green) are marked by arrows at the N-termini and purple lines below each protein
schematic underscores the regions expressed as recombinant proteins. The calculated molecular weights of these recombinant proteins are noted in
Table 1.
doi:10.1371/journal.pone.0063888.g001
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All Eleven pvmsp3 Gene Transcripts were Detected in
P. vivax Blood-stage Parasites
We set out to determine whether all eleven putative pvmsp3
genes were transcribed in blood-stage infections, or only a subset.
If each of these genes proved to be transcribed, it was also
important to know when, during the life cycle of the parasite, these
transcripts were being produced and their abundance. To achieve
this aim, gene-specific primer sets based on the P. vivax Salvador I
strain sequences (Table S1) were tested in PCR and RT-PCR
experiments using P. vivax Salvador I strain gDNA and cDNA as
templates, respectively. The primer pairs were strategically
designed to generate products of different sizes to distinguish
and unambiguously confirm the specific expression of individual
gene family members. The cDNA was produced from total RNA
representing predominantly P. vivax Salvador I strain schizonts
from a S. boliviensis blood-stage infection. The expected product
sizes for all eleven genes were obtained in all reactions performed
with gDNA and cDNA (Fig. 3). The melting curve generated with
SYBR Green after PCR and RT-PCR amplifications showed
similar, sometimes identical, melting temperatures (Tm) between
the two templates (Fig. 3). These primer pairs were also evaluated
for their ability to amplify the individual pvmsp3 genes from P. vivax
gDNA of the Belem strain. No amplicons were detected for
pvmsp3.1, 3.2, 3.3, 3.5, and 3.6 from this strain, while amplicons
were detected for the rest of the genes (data not shown). In these
reactions, the retrieval of all pvmsp3 genes would not be expected,
due to polymorphisms between the respective gene sequences
represented by the oligonucleotide primer pairs, or possible
differences in the number of pvmsp3 genes maintained in each
strain.
Next, we sought to determine whether each of the pvmsp3
transcripts from the P. vivax Salvador I strain was similarly
expressed, or not. Real-time quantitative qRT-PCR assays were
carried out with Taqman probes for specificity to quantify and
compare the pvmsp3 transcript levels of each family member
present in predominantly trophozoite or schizont total RNA
samples, purified from P. vivax Salvador I strain infected RBCs
generated from S. boliviensis blood-stage infections (Table S3 and
Fig. 4). The real-time qRT-PCR results confirmed that all eleven
pvmsp3 genes from the Salvador I strain of P. vivax were transcribed
during the blood-stage cycle, but at different levels. The detected
transcript levels of the different members of the gene family
showed between 0.7- to 25.5-fold changes relative to the gDNA
calibrator sample. The overall transcription level of the pvmsp3
Figure 2. Three motifs are common to all known Plasmodium MSP3 proteins. Putative protein sequences used to generate these analyses
were obtained from the gene IDs presented in Table S2. 2A. The conserved NLRNG motif, common in all MSP3 proteins is evident at the N-termini, 8–
16 amino acids downstream of the putative signal peptide cleavage site (underlined). 2B. One typical tandemly-repeated heptad motif with the
consensus sequence AXXAXXX to form a-helical coiled-coil structures were found at all MSP3 proteins including PfMSP3, PkMSP3, and PcyMSP3
(details in Fig. S2). 2C. The glutamate-rich motif exists in all MSP3 C-termini (details in Fig. S3), this hydrophilic domain is characterized by a high
content of acidic amino acids in clusters, particularly glutamates.
doi:10.1371/journal.pone.0063888.g002
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genes was below a 6-fold change relative to gDNA in both the
trophozoite and schizont stages. However, in the trophozoite-stage
sample, transcript levels for the pvmsp3.1 (pvmsp3-c) and pvmsp3.9
genes showed 25.5- and 9.9-fold changes, respectively, and in the
schizont stage, pvmsp3.2, pvmsp3.7 and pvmsp3.9 transcripts showed
.6-fold increases relative to gDNA. The comparison of the levels
of any pvmsp3 gene transcript between the trophozoite and
schizont stages revealed two genes with noticeable transcriptional
distinctions: pvmsp3.1 (pvmsp3-c), which decreased 4.5-fold, and
pvmsp3.2, which increased 6.9-fold. The products generated from
these experiments were also separated by agarose electrophoresis
to confirm the real-time PCR results (data not shown).
Recombinant PvMSP3s Contain Antigen-specific and
Cross-reactive B Cell Epitopes
To support investigations regarding the expression of the
PvMSP3 family, and to specifically distinguish potential differences
in protein expression between family members, recombinant
proteins and specific antisera were produced representing each
member of the family. The recombinant proteins produced
included the unique central coiled-coil regions of PvMSP3.1
through PvMSP3.9, the coil-coiled region plus the C-terminal of
PvMSP3.10 (PvMSP3-a) and the near full-length sequence of
PvMSP3.11 (Fig. 1B).
The antiserum produced against each recombinant PvMSP3
showed extensive cross reactivity as determined by immunoblot
(Fig. S5), preventing the use of these antisera to identify the
expression of the individual proteins. The cross-reactive antibodies
from each specific rPvMSP3 antiserum were eliminated by affinity
purification. Individual rPvMSPs were selectively bound to Affi-
Gel beads and used to adsorb antibody reactivities in a strategic
manner, starting with the strongest cross-reactivities (Fig. S6). For
example, cross-reactive antibodies present in the rPvMSP3.1
antiserum were removed by serial passage through affinity
columns containing rPvMSP3.2, rPvMSP3.8, and rPvMSP3.9
proteins. We found that it was not necessary to run each antiserum
through all ten protein-coupled resins. Antibodies specific to each
PvMSP3 family member were attained after three to seven
sequential passages over different selected affinity columns. These
results indicate that each rabbit antiserum contained antibodies
that were specific for each rPvMSP3 immunogen, as well as cross-
reacting antibodies, which could be removed by strategic
adsorption procedures.
Antibodies recognizing the central domain of most PvMSP3s
(rPvMSP3.1 - rPvMSP3.9) did not recognize rPvMSP3.10 or
rPvMSP3.11, expressed as full-length proteins. In contrast, the
anti-rPvMSP3.10 and anti-rPvMSP3.11 sera recognized all of the
other rPvMSP3s but did not cross-recognize each other. All anti-
rPvMSP3 sera did not recognize unrelated His-tagged recombi-
nant proteins cloned in the same expression vector or E. coli lysates
(Fig. S5).
PvMSP3 Family Members are Differentially Expressed in
Schizonts
The expression of the PvMSP3 family was further evaluated by
quantitative immunoblot assays. Affinity-purified, PvMSP3-specif-
ic antisera were used to probe immunoblots containing P. vivax
proteins extracted from infected RBCs containing late trophozo-
ites and schizonts of different stages of maturity from P. vivax
(Salvador I strain) and Belem strain parasites (Fig. 5). Ten of the
eleven predicted PvMSP3 proteins (PvMSP3.1 through
PvMSP3.10) were detected in the Salvador I strain, but at
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detected in these preparations. An especially large (47.3%) amount
of the total amount of PvMSP3 detected corresponded to
PvMSP3.9. By comparison, ,0.8% of the total PvMSP3 protein
corresponded to PvMSP3.4 or PvMSP3.8. The comparative levels
of the originally described PvMSP3 family members PvMSP3.1
(PvMSP3-c), PvMSP3.3 (PvMSP3-b) and PvMSP3.10 (PvMSP3-
a) were found to be approximately 15.3%, 6.5%, 14.2%,
respectively. Antisera reactive with PvMSP3.1, 3.2, 3.3, 3.9 and
3.10 also recognized small fragments, presumably breakdown
products. As noticed in previous studies, likely due to aberrant
migration of coiled-coil proteins [13,14], the apparent molecular
weights of PvMSP3s after polyacrylamide gel separation were at
least 50% greater in size than their predicted value based on
deduced protein sequences (Fig. 5, Table 1).
Eight antisera showed cross reactivity with the Belem strain
rPvMSP3 proteins, in support of the likelihood that there is cross-
reactivity of antibody immune responses against different MSP3
family members expressed in human infections. Predicted
counterpart PvMSP3.1, 3.5, 3.6, 3.7, 3.8, 3.9 and 3.10 proteins
were recognized, but not 3.2, 3.4 and 3.11. PvMSP3.11 was not
expressed in either strain. Of potential significance in terms of
understanding the function and relative immunodominance of
these proteins, PvMSP3.9 was detected in the greatest abundance
in both strains.
We also tested the reactivity of the panel of antibodies against P.
cynomolgi (Berok strain) and P. knowlesi (H strain) schizont extracts in
immunoblots. P. cynomolgi extracts were detected by all rPvMSP3
antisera except anti-rPvMSP3.4 and PvMSP3.5. Fewer positive
reactions were detected in P. knowlesi (Fig. S7). Only two MSP3
proteins are present in P. knowlesi. They are encoded on different
chromosomes and have a high degree of homology in the regions
flanking the central coiled-coil domain ([36] and unpublished
data).
Native PvMSP3 Proteins were Detected on the Merozoite
Surface
The expression of native PvMSP3 family members in the
infected RBCs was then studied using the affinity purified
rPvMSP3 antibody reagents. Indirect immunofluorescence assays
were conducted using each of the affinity purified rPvMSP3
antibodies, DAPI nuclear stain and a well-characterized PvMSP1
monoclonal antibody [37] for co-localization studies on blood
smears containing P. vivax (Salvador I strain) trophozoites,
schizonts and free merozoites (Fig. 6). Several of the PvMSP3
fluorescent patterns appeared to fill the area surrounding the
differentiated merozoites within the parasitophorous vacuole.
Specifically, eight of the proteins (PvMSP3.2, 3.3, 3.5, 3.6, 3.7,
3.8, 3.9 and 3.10) were detected in mature schizonts. Three of the
proteins (PvMSP3.6, PvMSP3.7 and PvMSP3.10) were also
detected with free merozoites. Only two of the proteins (PvMSP3.7
and PvMSP3.10) were detected by IFA in trophozoites, schizonts
and free merozoites. Three proteins, PvMSP3.1, PvMSP3.4 and
PvMSP3.11 were not detected in these assays (not shown). The
fluorescent patterns observed by IFA for the various PvMSP3
antisera resemble that of a merozoite surface fluorescence pattern
exemplified by PvMSP1 antibodies, included in these assays for
comparison (Fig. 6).
PvMSP3.7 Uniquely Localizes to the Apical End of the
Merozoite
Unexpectedly, PvMSP3.7 specific antiserum produced a distinct
fluorescent pattern in both mature schizonts and free merozoites
that was not typical of a MSP fluorescent pattern and was not
suggestive of localization in the PV space. Rather, the observed
pattern was typical for antigens localized in organelles at the apical
end of merozoites, in this case as a large single dot. Moreover,
immunoblot experiments distinctly detected a protein of about 200
kDa in both Salvador 1 and Belem strain parasites without any
other bands detected. These data suggest that this gene, despite
being denoted as pvmsp3.7, based on the criteria established and
summarized above for MSP3s, encodes a unique protein that
becomes specifically expressed at the apical pole of merozoites
(Fig. 6).
Discussion
This study presents a detailed analysis of the clustered 11-
member pvmsp3 gene family in the prototype genome of the
Salvador 1 strain of P. vivax [30] and we show that 10 of the 11
predicted PvMSP3 proteins are expressed. Transcripts for all 11
genes were detected in trophozoite and schizont parasite RNA
preparations. While we confirmed the expression of 11 transcripts,
there were distinct differences in the amount of the various pvmsp3
transcripts detected, which could reflect differential expression or





(b) PvMSP3.4 PvMSP3.5 PvMSP3.6 PvMSP3.7 PvMSP3.8 PvMSP3.9
PvMSP3.10
(a) PvMSP3.11
PvMSP3.1 (c) 41 31.6 34 31.8 35.5 29.9 36.7 29.4 34.8 19.2
PvMSP3.2 56.8 31.4 32.7 31.8 37.6 28.5 36.8 27.8 33.3 18.5
PvMSP3.3 (b) 47.9 48.5 34.1 34.1 31.8 34 32.5 31.2 32 18.2
PvMSP3.4 45.4 46.7 52.3 72.6 33 44.8 33.5 41.8 29.9 16.6
PvMSP3.5 45.1 46.4 51.5 83.4 33.4 47 32.8 42.9 29.6 16.1
PvMSP3.6 54.5 55.3 50 47.9 48 29.5 81.8 29.3 40.1 19.2
PvMSP3.7 42.7 44 49.6 61.2 63.8 44.4 30 63.2 29.9 16.4
PvMSP3.8 55.9 55.5 50.5 49.4 48.1 87.8 45.7 29.2 39.9 20.5
PvMSP3.9 41.5 42.2 48.3 57.7 59 43.1 74.8 43.4 27.5 14.6
PvMSP3.10 (a) 54 51.2 47.6 43.7 43.3 59.4 43.2 58.2 40.8 19
PvMSP3.11 27.6 27.2 25.3 23 23.3 27.6 23.1 27.9 20.8 27.7
Similarities (italics) and identities (bolded) were generated with the MatGAT 2.0 program (http://www.bitincka.com/ledion/matgat/) and the BLOSUM50 scoring matrix.
doi:10.1371/journal.pone.0063888.t002
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stability of the transcripts. These results could be explained by
differences in actual transcription, post-transcriptional turnover of
the RNA, less than 100% purity of the stage-specific samples, or
the less than perfect integrity of the RNA samples with induced
bias in the RT-PCR experiments. Only pvmsp3.11, the smallest of
the gene family members and located at the end of the cluster,
while transcribed in the blood stages, was not expressed as a
protein detectable by either immunoblot using parasite lysates or
IFA. We attempted but were not able to amplify transcripts that
could represent polycistronic messages supporting the view that
each gene is driven by its own promoter, as is typically the case in
Plasmodium [38], with few exceptions reported [39,40].
The fact that as many as 10 of the 11 pvmsp3 genes have been
shown here to be translated, with the expression of most members
confirmed during the trophozoite and schizont stages of develop-
ment, suggests that the parasite maintains the expression of
multiple structurally similar but highly polymorphic proteins with
putative redundant functions. However, certain members may also
have the potential to perform unique functions. The latter
possibility is supported by the fact that the timing of expression
is not identical, and the expression patterns and locations were not
the same for all family members. The timing of expression and
precise localization of the PvMSP3s differ in trophozoites,
schizonts or free merozoites, with the expression of the majority
of the proteins confirmed, as anticipated, in the schizont stage.
Together, this finding also supports the view that the role of each
individual PvMSP3 may be unique, yet complementary. An
alternative possible outcome that might have been observed is the
restricted expression of just one or a few members of the pvmsp3
gene family at a given time or in certain strains as has been
Figure 3. Comparison between gene and transcript amplification of each pvmsp3. Amplification products are shown after electrophoresis
in 1.5% agarose gels. Top panel: PCR products from genomic DNA; bottom panel: RT-PCR products from cDNA.
doi:10.1371/journal.pone.0063888.g003
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Figure 4. Stage-specific transcriptional level of the pvmsp3 gene family members evaluated by real-time PCR. The fold change of each
pvmsp3 transcript is shown from trophozoite- and schizont-stage RNA samples relative to genomic DNA.
doi:10.1371/journal.pone.0063888.g004
Figure 5. Native protein expression of the PvMSP3 family members by quantitative immunoblot. Plasmodium vivax parasite extracts
representing late-stage trophozoites and early schizonts from the Belem strain (B) or schizont stage from the Salvador I strain (S) were separated by
SDS-PAGE, transferred to nitrocellulose membranes and probed with primary antisera at 1:10,000 dilution. The expression level of each gene in the
Salvador I strain refers to the relative percentage of all PvMSP3 family members (red). Asterisks mark the position of the various MSP3 proteins of the
expected size recognized by specific antisera. A 40 kDa band was consistently detected in blots using Belem strain and may be accounted as non-
specific reactivity.
doi:10.1371/journal.pone.0063888.g005
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reported for the large var gene family, which encodes variant
antigens that become expressed at the surface of P. falciparum
infected red blood cells [41]. Some members of the ebl and rbl
invasion ligand gene families, on the other hand, may represent
redundant copies and provide alternative ligands for entry into
erythrocytes [12,42].
Consistent with global gene expression studies using a combi-
nation of microarray and proteomic technology, whereby tran-
scripts and protein expression in Plasmodium do not always coincide
[43], the amount of individual pvmsp3 transcripts as determined by
quantitative RT-PCR at a particular stage did not necessarily
correlate with the amount of protein detected by immunoblot or
IFA. For example, in the schizont stage, where expression of
MSP3s would be expected, the highest level of transcripts detected
corresponded to pvmsp3.2, followed by pvmsp3.7, pvmsp3.9 and
pvmsp3.11. However, the most abundant protein detected was
PvMSP3.9, equivalent to almost half the amount of the total
PvMSP3 produced from all members combined. The gene family
could be evolving such that there is a level of acceptable relaxation
in the control of expression and redundancy in function of the
members of this family. PvMSP3.1 (PvMSP3-c), on the other
hand, showed a level of high protein expression by immunoblot
(15.3% of total amount of PvMSP3 proteins), but was not detected
at all by IFA on air-dried trophozoites and schizonts. This result
suggests that the B cell epitopes in the native protein are mostly
conformational and the rabbit antibody response generated
against the PvMSP3.1 recombinant protein may have been mostly
against linear epitopes.
Previous studies on P. vivax (Belem strain) using a suspension
staining method showed that PvMSP3.10 (PvMSP3a) and
PvMSP3.3 (PvMSP3b) localized to the surface of free merozoites
[13,14]. The fluorescence pattern on air-dried parasites diffusely
covered the body of the parasite during early stages of schizogony
and the typical ‘‘bunch of grapes’’ pattern was only revealed in
fully segmented schizonts, consistent with the proteins ultimate
presence at the surface of the matured merozoites. Since PvMSP3s
Figure 6. Immunofluorescence reactivity of P. vivax MSP3 proteins in Salvador I parasites. Air-dried thin smears were probed with each
adsorbed rabbit anti-rPvMSP3 serum, followed by goat anti-rabbit IgG conjugated with Alexa 488 (green). A positive monoclonal antibody, 3F8.1A2,
was included to detect PvMSP-1 followed by goat anti-mouse IgG conjugated to Alexa 555 (red). Parasite nuclei were stained with DAPI (Blue) in
ProLongH Gold antifade reagent. Tr = trophozoites, Sz = schizonts, Mz = free merozoites. A merozoite surface protein fluorescence pattern was
observed with each anti-rPvMSP3 on the schizont stage except for anti-rPvMSP3.7 (light blue square).
doi:10.1371/journal.pone.0063888.g006
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do not have transmembrane domains, it was thought that these
soluble proteins could associate with other merozoite surface
proteins through protein-protein interaction by means of the
coiled-coil domain [13]. In this study, most of the PvMSP3-specific
antibodies reacted with segmented schizonts localizing to the
merozoite surface and the parasitophorous vacuolar space (Fig. 6
and S4). The lack of reactivity on air-dried free merozoites with a-
rPvMSP3.2, rPvMSP3.3, rPvMSP3.8 and rPvMSP3.9 (Fig. 6) may
be due to low-affinity interactions with the free merozoite surface,
a lack of antibody recognition of native protein epitopes, because
the antigen is not present at the free merozoite surface or some
combination of these possibilities.
Most uniquely in respect to the above spatial patterns of the
majority of MSP3 family members, antibodies against the coiled-
coil region of PvMSP3.7 have localized this protein at the apical
pole of merozoites during late schizogony and in free merozoites,
clearly differentiating this protein and its possible function from
the other PvMSP3 family members. A specific protein band of
,200 kDa was detected in Salvador I and Belem strain lysates,
without any additional bands that would suggest the presence of
multiple proteins with cross reactive epitopes. Proteomic experi-
ments analyzing anti-rPvMSP3.7 immunoprecipitates would
therefore be expected to corroborate this result. Proteins that
localize to the apical pole of merozoites tend to be involved in the
recognition and invasion of host erythrocytes and are thus also
regarded as potential vaccine targets [8–12]. It remains to be
determined whether this protein specifically localizes to the
merozoite’s micronemes, rhoptries or other organelles, but it
certainly warrants further study, particularly since relatively few
proteins have been defined at the apical pole of P. vivax merozoites.
Future experiments disrupting or altering the expression of
PvMSP3.7 or other members of the family will be required to
study the specific function of each PvMSP3, and determine which
if any, or what set of PvMSP3 proteins, are essential for the
parasite’s survival or alter the parasite’s growth. It is of interest in
this regard that disruption of the first-discovered msp3 gene in P.
falciparum, now designated as pfmsp3.1 [35], as well as pfmsp3.3 and
pfmsp3.7 caused no apparent change in the parasite’s growth,
multiplication and viability in in vitro cultures [44,45]. Only one
study has been reported to date showing the successful genetic
manipulation of P. vivax, and this has been via transient
transfection of the parasite [46]. Genetic integration has been
achieved with P. cynomolgi [47], and this species can also be used as
a model for such studies.
Comparing and contrasting the MSP3 members from P.
falciparum and other primate malaria species with the P. vivax
proteins have identified specific characteristics, one of the most
curious being the N-terminal NLRNG motif present in the
sequences of all eleven PvMSP3 family members, 8–17 amino
acids downstream from the putative signal peptide. The function
of the NLRNG motif is not known. We speculate that it may have
a role in trafficking and localization of these proteins, or be
essential for their conformation. This sequence is strikingly
conserved across the primate malaria species (P. falciparum, P.
knowlesi, P. cynomolgi and P. vivax), to the extent that it has become
recognized as a molecular signature for MSP3 proteins [13,14,35].
The identification of this motif amidst otherwise diverse amino
acid sequences was, in fact, instrumental in the recognition of the
six msp3 family members in P. falciparum [35], particularly in the
absence of a central domain with heptad repeats in all but the first
relatively small (48 kDa) member discovered in P. falciparum
(PfMSP3.1) [16,48].
It is intriguing that each of the P. vivax and simian malaria msp3
encoded proteins have a predominant central domain with
predicted coiled-coil structure (Fig. 1B, S2 and Table 1), while
this is not typically the case for the P. falciparum MSP3 family [35],
with the exception of PfMSP3.1. PfMSP3.1 has three blocks of
tandemly repeated heptads with the consensus sequence AX-
XAXXX and predicted to form coiled-coil structures [16,17]. In
contrast, the central region of each PvMSP3 contains as many as
24 blocks of heptad repeated motifs, and a wide range of predicted
coiled-coil structures covering 66.1–84.2% of the protein (Fig. 1B
and S2). The MSP3 families are otherwise quite different between
P. vivax and P. falciparum. The C-terminal domain in PfMSP3.1
(and the other PfMSP3s [35]) is characterized by the presence of a
leucine-zipper, which was shown to be important for the formation
of dimers and tetramers [19]. The leucine-zipper motif is not
present in any of the P. vivax MSP3s, raising questions about the
higher potential structural complexity of these proteins and how
they may form.
While the central coiled-coil structure may function as
previously proposed to enable the positioning of this protein at
the surface of merozoites, particularly in the absence of a C-
terminal hydrophobic transmembrane region or GPI anchor, since
most PfMSP3 family members do not have central coiled-coils
regions, surface localization may not be the primary role of this
family of proteins [35] and the same may be true for P. vivax. It
remains conceivable that these proteins may have a critical
primary role in the parasitophorous vacuole, as they sometimes
appear to be abundantly expressed in the space surrounding the
developing schizonts. Like PfMSP3 [29,48], they may also
function to elicit antibody-dependent cellular inhibition (ADCI)
activity as a means to control the rise in parasitemia. This
mechanism has not yet been demonstrated in P. vivax, though it
largely forms the basis of developing effective PfMSP3 vaccines
[24,25,49,50].
If PvMSP3 vaccines are to be pursued, a more thorough
understanding of the potential for diversity [21,22] and immuno-
genicity of all members of this family will be important. In malaria
endemic areas, PfMSP3 alleles have been shown to induce allele-
specific immunity under natural immune selection [51,52]. We
detected extensive cross reactivity in the antibody responses
generated against all 11 recombinant PvMSP3s, suggesting that
the naturally acquired immune response generated to each protein
may provide broad protection against the potential repertoire of
expressed proteins; however, this needs to be analyzed in the field,
complementing the few studies published to date showing the
presence of naturally acquired immunity to PvMSP3-a [26–28].
Cross-reacting antibodies could easily be removed by running the
various anti-rMSP3 sera through columns containing selected
recombinant proteins, but not the complete panel, suggesting that
these proteins have specific as well as shared B cell epitopes.
In summary, we have characterized the expression profiles of 11
pvmsp3 gene family members, which are positioned in tandem in a
head-to tail fashion in chromosome 10 in the P. vivax (Salvador I
strain) genome. We show that all 11 pvmsp3 genes from the P. vivax
Salvador I strain (propagated in S. boliviensis monkeys) were
transcribed in blood-stage parasites, and ten were expressed as
protein, with eight PvMSP3s confirmed in mature schizonts/
merozoites, and one localizing to the merozoite’s apical pole. The
function of each protein is unknown, and naturally acquired
immune responses have so far only been studied against
PvMSP3.10 (PvMSP3-a) [26–28], leaving much to be understood
about the biological and immunogenic role this family of proteins
has in terms of immunomodulation and protection. Finally, just as
pvmsp3-a and pvmsp3-b have become genetic markers of diversity
and tools for studying population genetics of P. vivax [213–23,53–
60], other members of the family may be similarly suited.
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Materials and Methods
Ethics Statement
All animal experiments in the current study were conducted in
AAALAC-accredited facilities at the Yerkes National Primate
Research Center in accordance with the Animal Welfare Act and
the Guide for the Care and Use of Laboratory Animals. All
experimental protocols were approved by Emory University’s
Animal Care and Use Committee. Adult Bolivian squirrel
monkeys (Saimiri boliviensis) were housed indoors under conditions
of controlled temperatures (67 to 77F) in same-sex pairs. Each
cage was equipped with perches and at least the minimum amount
of floor space required by federal rules, regulations, and guidelines.
Animals were fed a diet of LabDiet New World Monkey Diet
(Richmond, IN) twice daily. Peanuts and at least 1/4 orange were
offered as enviromental enrichment. All animals are monitored
daily by veterinary staff for potential health problems. All animals
were trained by experienced personnel to voluntary present at the
front of the cage for skin prick using positive reinforcement. For
large blood collection volumes, animals were sedated with
Ketamine (dose/route) or Telazol (dose/route) to minimize
distress. No animals were sacrificed in this study.
Parasite Collection, Genomic DNA and RNA
Plasmodium vivax (Salvador I and Belem strains) [61,62] parasites
were obtained from blood-stage infections in Saimiri boliviensis
monkeys. The P. vivax late-stage trophozoite-infected erythrocytes
or early schizonts were purified as described previously [61] and
aliquoted samples were stored as frozen stocks. Genomic DNA
(gDNA) was extracted as described previously [63]. Total RNA
was extracted from the Salvador I strain samples using a
RiboPureTM-Blood kit (Ambion), followed by two rounds of
DNase I digestion to remove any remaining gDNA. Since the
pvmsp3 genes have a one-exon gene structure, trace contamination
of gDNA in RNA samples would dramatically affect the results of
quantitative real-time Reverse Transcription - Polymerase Chain
Reactions (qRT-PCRs). DNA contamination was evaluated by
PCR amplification of total RNA samples without reverse
transcription using Taq DNA polymerase (Invitrogen), either a
weak or no amplicon was detected, thus, we concluded that our
RNA samples contained little or no gDNA.
Polymerase Chain Reaction and Reverse Transcription-
PCR
First strand complementary DNA (cDNA) was synthesized using
the SuperScriptTM III First-Strand Synthesis System (Invitrogen)
with an oligo(dT)20 primer at 50uC, and resulting cDNA samples
were stored at 220uC and thawed as needed for RT-PCR studies.
PCR and RT-PCR were performed using gDNA or single strand
cDNA as templates, respectively, the SYBR Green PCR Master
Mix system (Applied Biosystems), the iCycler machine (Bio-Rad)
and gene-specific primers (Table S1). Amplification conditions
consisted of one cycle of 15 min at 95uC followed by 45 cycles of
95uC for 30 sec, 58uC for 15 sec, and 72uC for 60 sec. At the end
of the reactions, using SYBR Green dye, the melting curve of each
sample was acquired and analyzed. After amplification, the size of
the PCR products amplified from both gDNA and cDNA were
analyzed by electrophoresis on 1.5% agarose gels.
Real-time Quantitative RT-PCR
Real-time qRT-PCR was performed using TaqManH Universal
PCR Master Mix Kit (Applied Biosystems) and the iCycler (Bio-
Rad) detection system. An initial incubation at 55uC for 2 min
activated the AmpErase UNG (degradation of potential carry-over
DNA contamination). Then, amplification conditions consisted of
one cycle of denaturation (95uC, 10 min) and 45 cycles of
amplification (95uC, 15sec, and 60uC, 1 min). 25 ul reactions
contained 1 ng of gDNA or cDNA, 0.3 mM each primer, 0.2 mM
Taqman probe and 12.5 ml of TaqManH Universal PCR Master
Mix. Real-time qRT-PCR experiments using pairs of primers
(Table S1) representing each of the 11 pvmsp3 genes were repeated
in duplicate including the P. vivax seryl-tRNA synthetase gene as
an internal control and both stage-specific cDNA and gDNA as
templates. Negative controls without primers were also included in
the qRT-PCR amplifications.
qRT-PCR Data Analysis using the 22DDCt Method
The relative quantification method was used to measure gene
transcription levels. First, the amplification efficiency of primers
pairs representing the 11 pvmsp3 genes were validated using
dilutions of gDNA [64]. The P. vivax seryl-tRNA synthetase gene
served as an internal control. The validation experiment, using
gDNA diluted in a 100-fold range, demonstrated that the
efficiencies of all primer sets amplifying the pvmsp3 gene family
members, and the internal control reference gene, were approx-
imately equal (data not shown). P. vivax Salvador I gDNA, known
to harbor single copies of each msp3 gene family, was used as a
calibrator in the qPCR, and data was analyzed by the 22DDCT
method [64]. To calculate the relative quantification of each
pvmsp3 gene, the DDCt formula was used as follows DDCt = (Ct,
pvmsp3 2 Ct, pvseryl-tRNA synthetase)x – (Ct, pvmsp3 - Ct, pvseryl-
tRNA synthetase)y, where x= cDNA and y = gDNA.
Production of Eleven PvMSP3 Recombinant Proteins in
Escherichia coli
The alanine-rich coiled-coil central domains of all but one
PvMSP3 were expressed as recombinant fusion protein (rPvMSP3)
in E. coli using the ChampionTM pET200 Directional TOPOH
expression vector (Invitrogen), the PvMSP3.10 (PvMSP3a) gene
was alternatively expressed in the vector pET-24d(+) expression
vector (Novagen). All fragments were amplified from P. vivax
(Salvador I) gDNA using high fidelity KOD DNA polymerase
(Novagen) and directional ligation. Positive clones were confirmed
by DNA sequencing and subsequently transformed into BL21
StarTM (DE3) E. coli cell (Invitrogen) for expression. Fusion
proteins were induced by the addition of 1 mM isopropyl-b-D-
thiogalactopyranoside (IPTG) at 37uC for 3 hr. Recombinant
proteins (rMSP3s) were expressed as 6X-His tagged fusion proteins
and were purified using a combination of HisTrapTM HP columns
(Amersham) and gel filtration or anion exchange columns. New
Zealand White female rabbits were immunized with the PvMSP3
recombinant proteins for production of a set of specific polyclonal
antisera following a three-dose immunization schedule (Covance).
Reactivity of each rabbit polyclonal serum was tested against its
own recombinant and the other 10 recombinant proteins by
immunoblot. All rabbit antisera showed variable but selective
cross-reactivity against some rPvMSP3. Thus, the antisera were
adsorbed with highly reactive PvMSP3 recombinants coupled to
Affi-Gel 15 (Bio-Rad). Briefly, 1.5 mg of purified recombinant
protein was coupled to 2 ml Affi-Gel 15 using the recommended
protocol. After blocking the active protein binding ester sites with
1 M ethanolamine HCI (pH 8) and equilibration of the resin with
1xTBS containing 10% dry milk, 200 ml of each antiserum was
run through the Affi-Gel 15 column. The flow-through was then
run through columns containing other selected antigens that were
also causing cross-reactivity. All antisera showed no cross-
reactivity by immunoblot after performance of these adsorption
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procedures (Fig. S6). The affinity purified antisera were stored at
220uC in 10% dry skim milk.
Indirect Immunofluorescence Assays
Indirect immunofluorescence assays (IFA) were conducted on
air-dried thin smears of P. vivax (Salvador I strain) iRBCs purified
from blood-stage infections of S. boliviensis, using Institutional
Animal Care and Use Committee approved protocols. When
necessary, the desired stage of parasite development was obtained
by maturation in short-term in vitro culture [61], and slide
collections were stored at 280uC as frozen stocks. Upon removed
from 280uC storage, the slides were immediately fixed with
0.25% paraformaldehyde in 1x DPBS at room temperature for 20
minutes. Primary antibodies, adsorbed rabbit anti-PvMSP3 sera
and PvMSP1 monoclonal antibody (3F8.1A2), were mixed and
diluted at 1:250 and 1:1000 respectively with 1x DPBS containing
0.2% fraction V bovine serum albumin (BSA), and added to each
slide and incubated at room temperature for 1.5 hr, followed by
three washes with 1x DPBS containing 0.2% BSA. Goat anti-
rabbit IgG (highly cross-absorbed by human and mouse IgG)
conjugated with Alexa 488 dye (Invitrogen) and goat anti-mouse
IgG (highly cross-absorbed by bovine, goat, rabbit, rat, and
human IgG and human serum) conjugated with Alexa 555 dye
(Invitrogen) were diluted at 1:100 and used as secondary
antibodies. Finally, the slides were washed four times with 1x
DPBS containing 0.2% BSA, mounted with ProLongH Gold
antifade reagent with DAPI (Invitrogen) and covered with a cover
slip. Antibody binding and DNA staining were assessed using a
Zeiss Z.1 fluorescence microscope.
Quantitative Immunoblots
Whole cell lysates of P. vivax Belem (trophozoite and early
schizonts) or Salvador I strains (schizonts) iRBCs were solubilized
with reducing (2-b-Mercaptoethanol) sample buffer. Ten ml of
sample were separated by SDS-PAGE and transferred to
nitrocellulose membranes using a Bio-Rad Mini Trans-Blot Cell
(Bio-Rad). The membranes were probed with adsorbed polyclonal
rabbit antisera (1:10,000) against each rPvMSP3 followed by goat
anti-rabbit serum 1:5000) conjugated to horseradish peroxidase
(Promega, Madison, WI, USA). The band intensities were
quantified using the Quantity One software (Bio-Rad) with the
adjusted volume method and expressed as a percentage of total
MSP3 protein. Simultaneously, duplicate samples were stained
with mixture antibodies of all eleven rabbit anti-PvMSP3 or
Ponceau S reagent after SDS-PAGE separation and nitrocellulose
membrane transfer for normalization of the protein concentration
in the parasite lysates.
DNA and Protein Sequence Analysis
The Multicoil software (http://groups.csail.mit.edu/cb/
multicoil/cgi-bin/multicoil.cgi ) was used to compare the input
amino acid sequence to a database of known parallel two-stranded
coiled-coils. A cutoff of 0.5 was applied for scoring the coiled-coil
structures present in the PvMSP3 predicted proteins. The putative
signal peptide cleavage site was predicted using SignalP 3.0
(http://www.cbs.dtu.dk/services/SignalP/) which uses the neural
network model [65]. The TMHMM Server v. 2.0 (http://www.
cbs.dtu.dk/services/TMHMM-2.0/) was used to search for
transmembrane domains. The GPI Modification Site Prediction
algorithm by Eisenhaber’s method [66] was used to evaluate the
presence of post-translational modifications (http://mendel.imp.
ac.at/gpi/gpi_server.html ). Conserved motifs were evaluated
using the MEME package (http://meme.sdsc.edu/meme4/cgi-
bin/meme.cgi).
Supporting Information
Figure S1 Coiled-coil region of the PvMSP3 protein
family members predicted by a program of Multicoil
(http://groups.csail.mit.edu/cb/multicoil/cgi-bin/mul-
ticoil.cgi) with 0.5 cut-offs for scoring a coiled-coil
structure. Below the amino sequence are the predicted frames
of the coiled-coils represented by the ‘abcdefg’ convention for
the heptad repeats. The repeated AXXAXXX sequence pattern
representing predicted coiled-coil heptads is marked by a red underline.
(PDF)
Figure S2 The typical tandemly-repeated heptad motif
AXXAXXX, predicted to form a-helical coiled-coil
structures, was found in the putative MSP3 proteins
analyzed (see sequence IDs in Table S2) using the
MEME algorithm (http://meme.sdsc.edu/meme4/cgi-
bin/meme.cgi). Numbers in parentheses refers to amino acid
position.
(PDF)
Figure S3 Glutamate-rich motifs from the C-termini of
MSP3 proteins. The high content of glutamic acid (E) residues
are present amidst other acidic amino acids in clusters, resulting in
hydrophilic C-terminal regions.
(PDF)
Figure S4 Immunofluorescence experiments showing
the expression of the PvMSP3 proteins in relation to
PvMSP1. Mixed stages of P. vivax (Sal 1) infected RBCs in air-
dried thin smears were stained with a mixture of antibodies
recognizing all PvMSP3 proteins (Green, Alexa 488). A monoclo-
nal antibody (3F8.1A2) was used to detect PvMSP1 (Red, Alexa
555). Parasite nuclei were stained with DAPI (Blue) in ProLongH
Gold antifade reagent. The slides were fixed with 0.25%
paraformaldehyde in 1x DPBS at room temperature for 20 min,
immediately upon removal from 280uC. 4A. Individual IFAs and
the merged co-localization images are shown. 4B. different layers
of one schizont were observed using a Zeiss LSM 510 META
confocal microscope. The upper panel shows the merged pictures
with the green (PvMSP3), red (PvMSP1), blue (parasite nuclei) and
brightfield channels, and the lower panel shows the merged
pictures without the brightfield channel.
(PDF)
Figure S5 Cross reactivity is not caused by recombinant
protein expression vector residues or 6xHis tag.
(PDF)
Figure S6 Cross-reactive antibodies present in the
rPvMSP3 antisera were removed by serial passage
through affinity columns.
(PDF)
Figure S7 Detection of PvMSP3 homologs PcyMSP3 and
PkMSP3 with rabbit antiserum against specific
rPvMSP3s. Same volume (10 ul) of P. cynomolgi and P. knowlesi
parasite extracts representing schizont stage from the Berok and H
strain respectively were separated by 7.5% SDS-PAGE, trans-
ferred to nitrocellulose membranes and probed with primary
antisera at 1:5,000 dilution. All membranes were exposed for the
same length of time for chemiluminesence detection.
(PDF)
Table S1 Primers used for gene-specific PCR, quanti-
tative real-time RT-PCR, and recombinant protein
expression.
(PDF)
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Table S2 Gene accession numbers or identification
numbers used for analysis.
(PDF)
Table S3 Raw data of qRT-PCR detection of transcript
level of PvMSP3 family members with TaqMan probes.
(PDF)
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